Your browser doesn't support javascript.
loading
Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy.
van Schaik, Mieke; de Vries, Aiko P J; Bemelman, Frederike J; Rabelink, Ton J; Trouw, Leendert A; van Kooten, Cees; Teng, Yoe Kie Onno.
Afiliación
  • van Schaik M; Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Vries APJ; Department of Nephrology and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
  • Bemelman FJ; Department of Nephrology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Rabelink TJ; Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
  • Trouw LA; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Kooten C; Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
  • Teng YKO; Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Kidney Int Rep ; 9(6): 1919-1922, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38899188
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Kidney Int Rep Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Kidney Int Rep Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos